Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: A meta-analysis

Journal of Zhejiang University: Science B

Volumn 15, Issue 3, 2014, Pages 256-263

  Wang, Xiao ^a   Shi, Lei Zhi ^a,b  

^a ZHEJIANG HOSPITAL   (China)

^b LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

Coronary artery disease; Matrix metalloproteinase 9; Meta analysis; Polymorphism

Indexed keywords

GELATINASE B;

ALLELE; ARTICLE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE CARRIER; EMBASE; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; MEDLINE; META ANALYSIS (TOPIC); PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 9; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84897033392     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1300088     Document Type: Article

References (38)

1. Alp, E., Menevse, S., Tulmac, M., et al., 2009. Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population. DNA Cell Biol., 28(7):343-350. [doi:10.1089/dna.2009.0866]
2. Asselbergs, F.W., Reynolds, W.F., Cohen-Tervaert, J.W., et al., 2004. Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease. Am. J. Med., 116(6):429-430.[doi:10.1016/j.amjmed.2003.10.025] (Pubitemid 38299491)
3. Blankenberg, S., Rupprecht, H.J., Poirier, O., et al., 2003. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation, 107(12):1579-1585. [doi:10.1161/01.CIR.0000058700.41738.12] (Pubitemid 36397324)
4. Brown, D.L., Hibbs, M.S., Kearney, M., et al., 1995. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation, 91(8):2125-2131. [doi:10.1161/01.CIR.91.8.2125]
5. Cho, H.J., Chae, I.H., Park, K.W., et al., 2002. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J. Hum. Genet., 47(2):88-91. [doi:10.1007/s100380200006]
6. Demacq, C., de Souza, A.P., Machado, A.A., et al., 2006. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects. Clin. Chim. Acta, 365(1-2):183-187. [doi:10.1016/j.cca.2005.08.017] (Pubitemid 43196436)
7. Demacq, C., Vasconcellos, V.B., Marcaccini, A.M., et al., 2008. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clin. Chem. Lab. Med., 46(1):57-63. [doi:10. 1515/CCLM.2008.014]
8. Fallah, S., Seifi, M., Ghasemi, A., et al., 2010. Matrix metal-loproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects. J. Clin. Lab. Anal., 24(5):305-310. [doi:10.1002/jcla.20406]
9. Galis, Z.S., Sukhova, G.K., Lark, M.W., et al., 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest., 94(6):2493-2503. [doi:10.1172/JCI117619] (Pubitemid 24379627)
10. Ghaderian, S.M., Akbarzadeh Najar, R., Tabatabaei Panah, A.S., 2010. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron. Artery Dis., 21(6):330-335. [doi:10.1097/MCA.0b013e32833ce065]
11. (-1562)T polymorphism in relation to ischaemic heart disease. Scand. J. Clin. Lab. Invest., 65(6):513-522. [doi:10.1080/00365510500206575]
12. Horne, B.D., Camp, N.J., Carlquist, J.F., et al., 2007. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am. Heart J., 154(4):751-758. [doi:10.1016/j.ahj.2007. 06.030] (Pubitemid 47429598)
13. Izidoro-Toledo, T.C., Guimaraes, D.A., Belo, V.A., et al., 2011. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 383(6):547-554. [doi:10.1007/s00210-011-0623-0]
14. Jefferis, B.J., Whincup, P., Welsh, P., et al., 2010. Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis, 208(2):557-563. [doi:10.1016/j. atherosclerosis.2009.08.018]
15. Johnson, C., Galis, Z.S., 2004. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler. Thromb. Vasc. Biol., 24(1):54-60. [doi:10.1161/01.ATV.0000100402.69997.C3] (Pubitemid 38082411)
16. Kai, H., Ikeda, H., Yasukawa, H., et al., 1998. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J. Am. Coll. Cardiol., 32(2):368-372. [doi:10.1016/S0735-1097(98) 00250-2] (Pubitemid 28396484)
17. Kim, J.S., Park, H.Y., Kwon, J.H., et al., 2002. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Med. J., 43(4):473-481. (Pubitemid 35012393)
18. Koh, Y.S., Chang, K., Kim, P.J., et al., 2008. A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction. Int. J. Cardiol., 127(3):430-432. [doi:10.1016/j.ijcard.2007.04.107] (Pubitemid 351885094)
19. Lacchini, R., Metzger, I.F., Luizon, M., et al., 2010. Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence. DNA Cell Biol., 29(11):649-655. [doi:10.1089/dna.2010.1056]
20. Loftus, I.M., Naylor, A.R., Goodall, S., et al., 2000. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke, 31(1):40-47. [doi:10.1161/01.STR.31.1.40] (Pubitemid 30035750)
21. Lopez, A.D., Mathers, C.D., Ezzati, M., et al., 2006. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 367(9524):1747-1757. [doi:10.1016/S0140-6736(06)68770-9] (Pubitemid 43767064)
22. Marenberg, M.E., Risch, N., Berkman, L.F., et al., 1994. Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med., 330(15): 1041-1046. [doi:10.1056/NEJM199404143301503] (Pubitemid 24106561)
23. Metzger, I.F., Luizon, M.R., Lacchini, R., et al., 2012. Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects. DNA Cell Biol., 31(4):504-510. [doi:10.1089/dna.2011.1388]
24. Morgan, A.R., Zhang, B., Tapper, W., et al., 2003. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J. Mol. Med. (Berl.), 81(5):321-326. (Pubitemid 36718329)
25. Nanni, S., Melandri, G., Hanemaaijer, R., et al., 2007. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms. Transl. Res., 149(3):137-144. [doi:10.1016/j.trsl.2006.09.001] (Pubitemid 46275571)
26. Newby, A.C., 2005. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev., 85(1):1-31. [doi:10.1152/physrev.00048.2003] (Pubitemid 40171256)
27. Nuzzo, D., Vasto, S., Balistreri, C.R., et al., 2006. Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from sicily. Ann. N. Y. Acad. Sci., 1089(1):496-501. [doi:10.1196/annals.1386. 048] (Pubitemid 47092101)
28. Opstad, T.B., Pettersen, A.A., Weiss, T.W., et al., 2012. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease. Clin. Chim. Acta, 413(1-2):113-120. [doi:10.1016/j.cca.2011.09.004]
29. Pasterkamp, G., Schoneveld, A.H., Hijnen, D.J., et al., 2000. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis, 150(2): 245-253. [doi:10.1016/S0021-9150(99)00371-8] (Pubitemid 30336536)
30. Pollanen, P.J., Karhunen, P.J., Mikkelsson, J., et al., 2001. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arterioscler. Thromb. Vasc. Biol., 21(9):1446-1450. [doi:10.1161/hq0901.095545] (Pubitemid 34219806)
31. Souza-Costa, D.C., Sandrim, V.C., Lopes, L.F., et al., 2007. Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis, 193(2):438-444. [doi:10.1016/j.atherosclerosis.2006.07.020] (Pubitemid 47058109)
32. Tayebjee, M.H., Lip, G.Y., Tan, K.T., et al., 2005. Plasma matrix metalloproteinase-9, tissue inhibitor of metallo-proteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am. J. Cardiol., 96(3):339-345. [doi:10.1016/j.amjcard.2005.03.072] (Pubitemid 41058855)
33. Wang, J., Warzecha, D., Wilcken, D., et al., 2001. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin. Sci. (Lond.), 101(1):87-92. [doi:10.1042/CS20000317] (Pubitemid 32634742)
34. Wang, L., Ma, Y.T., Xie, X., et al., 2012. Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population. Clin. Appl. Thromb. Hemost., 18(1):72-78. [doi:10.1177/10760296 11412365]
35. Welsh, P., Whincup, P.H., Papacosta, O., et al., 2008. Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men. QJM, 101(10):785-791. [doi:10.1093/qjmed/hcn088]
36. Zhang, B., Ye, S., Herrmann, S.M., et al., 1999a. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation, 99(14):1788-1794. [doi:10.1161/01.CIR.99. 14.1788] (Pubitemid 29181405)
37. Zhang, B., Henney, A., Eriksson, P., et al., 1999b. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum. Genet., 105(5):418-423. [doi:10.1007/s004390051124]
38. Zhi, H., Wang, H., Ren, L., et al., 2010. Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population. Mol. Biol. Rep., 37(1):13-20. [doi:10.1007/s11033-009-9482-x]